New tool predicts MS worsening after a first attack
Key Takeaway
A new tool predicted which people were more likely to have another attack or worsening disability after a first MS-like attack.
What They Found
Researchers built a tool to predict several outcomes after a first MS-like attack. They used records from Barcelona and checked the tool using records from Melbourne. It predicted most outcomes with moderate to high accuracy in the Melbourne group. It was less accurate at predicting disability worsening linked to an attack. In general, people rated at higher risk had new attacks or worsening disability sooner.
Who Should Care and Why
The study followed people who had a first attack that suggested MS. People in the Barcelona group were younger than 50 when symptoms began. They had visited the clinic within three months of that attack. The tool used information available during care, including age, brain scans, and treatment history. It aimed to estimate each person's risk of future attacks or worsening disability.
Important Considerations
Researchers followed 1,180 people in Barcelona and checked their predictions against 108 people in Melbourne. The tool was less accurate for some outcomes in the Melbourne group. These findings do not show that using the tool improves care or changes outcomes.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
11/1/2026
Learn how brain support cells may affect inflammation in MS, why their roles can change, and what th
Read More
11/1/2026
A study of 323 people with MS links blood chemicals to walking, thinking, and changes. Learn why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.